PCOS affects more than 1 in 10 women of reproductive age worldwide, making it one of the most common endocrine disorders in women. Yet despite its prevalence, it remains one of the most under-diagnosed and under-treated conditions in women's health. Research suggests that up to 70 percent of women with PCOS go undiagnosed, often spending years being told their symptoms are stress-related, weight-related, or simply normal. From irregular cycles and hormonal weight gain to mood instability, skin changes, and fertility struggles, the ripple effects of PCOS touch nearly every system in the body.
At BOND, our mission is to give women daily tools that support their biology, not suppress it. This PCOS Awareness Month, we're spotlighting the science behind one of the most promising and well-researched nutrients for women navigating PCOS-related challenges: inositol.
Understanding the Root Mechanisms of PCOS
PCOS is not a single disorder with a single cause. It is a systemic condition involving the interplay between insulin signaling, androgen production, ovarian function, and inflammation. At the center of many PCOS presentations is insulin resistance, which is estimated to affect 50 to 70 percent of women with the condition regardless of body weight.
When cells become less responsive to insulin, the pancreas produces more of it to compensate. Elevated insulin levels then stimulate the ovaries to produce excess androgens, particularly testosterone. This androgen excess is what drives many of the visible symptoms of PCOS: acne along the jawline, excess hair growth on the face and body, thinning hair at the scalp, and disrupted ovulation. The connection between insulin and androgens creates a self-reinforcing cycle that can be difficult to break without addressing insulin sensitivity directly.
Chronic low-grade inflammation is another key feature of PCOS that compounds these metabolic and hormonal disruptions. Elevated inflammatory markers like C-reactive protein (CRP), interleukin-6, and TNF-alpha are commonly found in women with PCOS and are associated with worsening insulin resistance and androgen excess. This inflammatory component helps explain why PCOS symptoms often extend beyond the reproductive system, affecting mood, energy, gut health, and skin.
This is where inositol enters the picture. Inositol is a naturally occurring compound that functions as a secondary messenger in insulin signaling pathways. By supporting how cells respond to insulin, inositol addresses one of the central drivers of PCOS at the root level rather than masking symptoms on the surface.
Clinically Studied Support for Women with PCOS
BOND's Myo and D-Chiro Inositol blend delivers the same 40:1 ratio validated in clinical studies to support hormone balance and metabolic health. This physiologically aligned ratio mirrors the body's natural distribution of these two inositol forms, offering targeted support for women experiencing PCOS-related symptoms.
Clinical research has shown that inositol supplementation at this ratio can help support ovulation in women with PCOS, with some studies showing ovulation restoration in up to 86 percent of participants. Inositol has also been studied for its role in supporting hormone balance by reactivating aromatase enzyme activity and helping to reduce excess androgen levels. Additional research points to its potential to support insulin sensitivity and help reduce sugar cravings, as well as to support mood stability and emotional regulation tied to cycle phases.
As highlighted in a recent narrative review published in Drug Design, Development and Therapy: "Therapies based on inositols are usually well tolerated and can be extended over time without relevant side effects."
Why the 40:1 Ratio Matters
Not all inositol supplements are created equal. The two most studied forms are myo-inositol and D-chiro-inositol, and they serve different functions in the body. Myo-inositol is the more abundant form and plays a primary role in insulin signaling and ovarian function. D-chiro-inositol is present in smaller amounts and is involved in androgen modulation and glycogen storage.
The 40:1 ratio reflects the natural physiological balance of these two forms in the human body. Research by Nordio and Proietti (2012) demonstrated that this specific ratio outperformed myo-inositol alone in restoring ovulation and improving metabolic markers in women with PCOS. This finding has been supported by subsequent research, including a 2025 narrative review by Lentini et al. that confirmed the physiological basis for the 40:1 ratio and its clinical relevance.
Taking D-chiro-inositol in excess can actually impair ovarian function by disrupting local myo-inositol availability in the ovaries. This is why the ratio matters, and why BOND formulated its inositol product to match the clinically studied proportion.
What Makes BOND Different
BOND's approach to PCOS support is grounded in the principle that effective supplementation should work with the body's existing biology, not override it. Our Myo and D-Chiro Inositol is formulated with the clinically aligned 40:1 ratio, contains no added flavors or sugars, and is designed for daily use as part of a comprehensive approach to hormone and metabolic health.
Unlike approaches that focus on suppressing symptoms, inositol works by supporting the signaling pathways that are already present in the body. For many women, this translates to meaningful changes in cycle regularity, mood stability, cravings, and energy levels when used consistently over time.
Key Clinical Studies on Inositol
The science behind inositol supplementation is robust, with decades of research examining its effects on metabolic, reproductive, and emotional health in women with PCOS and related conditions.
Gerli et al., 2007 conducted a randomized controlled trial showing that myo-inositol at 4 grams per day reduced insulin levels, testosterone levels, and BMI in women with PCOS compared to placebo.
Nordio and Proietti, 2012 compared the 40:1 myo-inositol to D-chiro-inositol ratio against myo-inositol alone and found that the combination ratio was more effective at restoring ovulation and improving metabolic markers.
Palatnik et al., 2001 demonstrated that myo-inositol supplementation improved PMDD symptoms including mood swings, irritability, and emotional sensitivity in women experiencing premenstrual dysphoric disorder.
Montanino Oliva et al., 2011 published in the Menopause Journal found that in postmenopausal women, 4 grams per day of myo-inositol over 12 months supported healthy insulin response, triglyceride levels, and blood pressure.
Lentini et al., 2025 published a comprehensive narrative review confirming that myo-inositol supports estrogen production while D-chiro-inositol supports androgen modulation, and that the 40:1 ratio is physiologically grounded in the body's natural inositol distribution.
Gul et al., 2025 conducted a randomized controlled trial comparing the 40:1 inositol blend to metformin and found that both approaches similarly supported insulin sensitivity, cycle regularity, ovarian function, BMI, and quality of life in women with PCOS.
Zhang et al., 2025 published a meta-analysis showing that myo-inositol supplementation supported egg quality, MII oocyte rates, and fertilization success in women undergoing IVF.
Beyond Inositol: A Whole-Body Approach to PCOS
While inositol is one of the most well-studied nutrients for PCOS support, managing the condition effectively often requires a broader approach. Nutrition plays a central role, particularly dietary patterns that support blood sugar stability and reduce systemic inflammation. Regular movement, even moderate activity like walking, has been shown to support insulin sensitivity independently of weight loss. Sleep quality and stress management also directly influence cortisol and insulin levels, both of which affect androgen production.
BOND's product line was designed to support women across these interconnected systems. Daily Balance provides comprehensive micronutrient support for hormone metabolism, and Cycle Care addresses the PMS and cycle symptoms that frequently accompany PCOS. Together with inositol, these products offer a foundation for daily support that works alongside diet, movement, and lifestyle.
Not sure which product is right for you? Take our Hormone Quiz for a personalized recommendation.
The Bottom Line
PCOS is not just irregular cycles. It is a complex, systemic condition with ripple effects on energy, mood, fertility, skin, weight, and long-term metabolic health. The good news is that research is advancing rapidly, and women have more evidence-based options than ever before. This PCOS Awareness Month, BOND is committed to shining a light on science-backed tools like inositol that help women feel more in sync with their bodies. Because every woman deserves to feel supported, not dismissed.
Works Cited
Gerli, S., et al. (2007). "Myo-Inositol in patients with polycystic ovary syndrome: a randomized, controlled trial." European Review for Medical and Pharmacological Sciences. PubMed
Nordio, M., and Proietti, E. (2012). "The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients." European Review for Medical and Pharmacological Sciences. PubMed
Palatnik, A., et al. (2001). "Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder." Journal of Clinical Psychopharmacology. PubMed
Montanino Oliva, M., et al. (2011). "Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome." Menopause Journal.
Lentini, M., et al. (2025). "PCOS and Inositols: Advances and lessons we are learning." Drug Design, Development and Therapy. Dove Press
Gul, H., et al. (2025). "Myo-inositol and D-chiro-inositol 40:1 vs. Metformin in PCOS." PubMed
Zhang, Y., et al. (2025). "Myo-Inositol and egg quality in IVF: A meta-analysis." Frontiers in Endocrinology. Frontiers
Leave a Comment